Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial

Published:2023-10 Issue: Volume:204 Page:26-28
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Shah Binita,Smilowitz Nathaniel R.,Xia Yuhe,Feit Frederick,Katz Stuart D.,Zhong Judy,Cronstein Bruce,Lorin Jeffrey D.,Pillinger Michael H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. White blood cell count and major adverse cardiovascular events after percutaneous coronary intervention in the contemporary era: insights from the PARIS study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry);Shah;Circ Cardiovasc Interv,2017

2. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits;Rogers;Proc Natl Acad Sci U S A,1998

3. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty;Inoue;J Am Coll Cardiol,1996

4. A prospective natural-history study of coronary atherosclerosis;Stone;N Engl J Med,2011

5. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients;Deftereos;J Am Coll Cardiol,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?;Cardiovascular Revascularization Medicine;2024-04

2. Update on the Role of Colchicine in Cardiovascular Disease;Current Cardiology Reports;2024-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3